KR20030018500A - Manufacturing method of composite radiating far-infrared ray - Google Patents
Manufacturing method of composite radiating far-infrared ray Download PDFInfo
- Publication number
- KR20030018500A KR20030018500A KR1020010052624A KR20010052624A KR20030018500A KR 20030018500 A KR20030018500 A KR 20030018500A KR 1020010052624 A KR1020010052624 A KR 1020010052624A KR 20010052624 A KR20010052624 A KR 20010052624A KR 20030018500 A KR20030018500 A KR 20030018500A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- far
- mixture
- elvan
- composition
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 239000002131 composite material Substances 0.000 title 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 31
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 24
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000002844 melting Methods 0.000 claims abstract description 8
- 230000008018 melting Effects 0.000 claims abstract description 8
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 8
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- 239000010453 quartz Substances 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 239000000049 pigment Substances 0.000 claims abstract description 4
- 238000001816 cooling Methods 0.000 claims abstract description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 14
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 13
- 229910052737 gold Inorganic materials 0.000 claims description 12
- 239000010931 gold Substances 0.000 claims description 12
- 229910052709 silver Inorganic materials 0.000 claims description 12
- 239000004332 silver Substances 0.000 claims description 12
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 238000003303 reheating Methods 0.000 claims description 2
- 230000003014 reinforcing effect Effects 0.000 claims description 2
- 238000005429 filling process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 6
- 239000000155 melt Substances 0.000 abstract description 3
- 238000011049 filling Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 1
- 239000013078 crystal Substances 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 5
- 235000012239 silicon dioxide Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 229910052593 corundum Inorganic materials 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 3
- 239000004575 stone Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 235000011116 calcium hydroxide Nutrition 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- -1 composed of elvan Substances 0.000 description 2
- 239000010431 corundum Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 229910000519 Ferrosilicon Inorganic materials 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- WMWXXXSCZVGQAR-UHFFFAOYSA-N dialuminum;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3] WMWXXXSCZVGQAR-UHFFFAOYSA-N 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000010433 feldspar Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 229910001751 gemstone Inorganic materials 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011044 quartzite Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/01—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics
- C04B35/16—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on silicates other than clay
- C04B35/18—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on silicates other than clay rich in aluminium oxide
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/653—Processes involving a melting step
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47C—CHAIRS; SOFAS; BEDS
- A47C27/00—Spring, stuffed or fluid mattresses or cushions specially adapted for chairs, beds or sofas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2103/00—Function or property of ingredients for mortars, concrete or artificial stone
- C04B2103/0068—Ingredients with a function or property not provided for elsewhere in C04B2103/00
- C04B2103/0076—Deodorizing agents
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2103/00—Function or property of ingredients for mortars, concrete or artificial stone
- C04B2103/0068—Ingredients with a function or property not provided for elsewhere in C04B2103/00
- C04B2103/0097—Anion- and far-infrared-emitting materials
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2103/00—Function or property of ingredients for mortars, concrete or artificial stone
- C04B2103/54—Pigments; Dyes
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2103/00—Function or property of ingredients for mortars, concrete or artificial stone
- C04B2103/60—Agents for protection against chemical, physical or biological attack
- C04B2103/67—Biocides
- C04B2103/69—Fungicides
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/62605—Treating the starting powders individually or as mixtures
- C04B35/6261—Milling
Abstract
Description
본 발명은 맥반석을 주재료로 한 원적외선 조성물에 요함부를 형성하여 이에 금과 은의 혼합물을 용융첨가하여 매트리스나 베게, 방석등에 부착 또는 매설하거나 목걸이 등의 장신구, 전자판 차단용품 등으로 사용할 수 있게 한 원적외선 방사용 조성물의 제조방법에 관한 것이다.The present invention forms a recess in the far-infrared composition mainly composed of elvan, and melts and adds a mixture of gold and silver to it so that it can be attached to or embedded in a mattress, a pillow, a cushion, or used as a jewelry such as a necklace or an electronic panel blocking product. It relates to a method for producing a spinning composition.
맥반석의 특성은 이미 널리 알려져 있지만, 이를 다시 설명하면 각종 유해성분의 흡착제거, 이온분해, 미네랄용출, 물의 산도조정 및 용존산소량을 증가시키는 등의 특성을 가지고 있다.The characteristics of elvan are already well known, but if they are described again, they have characteristics such as adsorption removal of various harmful components, ion decomposition, mineral elution, acidity adjustment of water, and increased dissolved oxygen.
이는 맥반석이 무수규산(SO2)과 산화알루미늄(Al2O3)이 주성분인 다공성 물질이며, 산화제이철, 칼슘, 망간, 게르마늄, 마그네슘 등의 미네랄 25종 성분을 포함하고 있어서 이를 방출하는 효과 등이 있기 때문인 것이다.It is a porous material in which elvan is the main component of silicic anhydride (SO 2 ) and aluminum oxide (Al 2 O 3 ), and it contains 25 kinds of minerals such as ferric oxide, calcium, manganese, germanium, magnesium, etc. This is because there is.
이러한 맥반석의 특성을 이용하여, 일반적으로는 맥반석을 물에 투입하여 물을 활성화시켜서 마시는데, 이렇게 하면 혈액개선 및 기타 성인병 질환의 예방 및 치료에 효과적이기 때문이다.By using the characteristics of the elvan, in general, elvan is added to the water to activate the water to drink, because it is effective in the prevention and treatment of blood improvement and other adult diseases.
맥반석이 외과적 및 내과적 질환을 예방 및 치료할 수 있는 것은 맥반석이 신체의 환부나 몸을 보통 이상으로 따뜻하게 해주며, 혈액순환을 촉진하고 세포작용을 돕기 때문인 것으로 알려져 있다.It is known that elvan can prevent and treat surgical and medical diseases because elvan causes the body's affected area or body to warm more than usual, promotes blood circulation and helps cell work.
맥반석이 질환의 치료에 사용되어지는 실례를 들면, 위장병의 경우에는 맥반석이 위점막을 보호하고 몸을 따뜻하게 하여 신진대사를 높이며 위장기능을 활발하게 하고, 간장병의 경우에는 글루쿠로닉산의 생성을 증대시켜 혈액 순환이 왕성해져서 혈액의 정화를 촉진시켜 병상이 호전되는 것으로 판단된다.For example, in cases of gastrointestinal disease, elvan has been found to protect the gastric mucosa, warm the body, increase metabolism, activate gastrointestinal function, and in the case of liver disease, produce glucuronic acid. Increased blood circulation is promoted to promote the purification of blood, which is believed to improve the condition.
당뇨의 경우에도 몸을 따뜻하게 하여, 혈중당분의 연소가 왕성하게 되므로 혈중의 당의 함량이 줄고, 췌장의 랑겔한스 세포의 재생으로 인하여 인슐린의 분비가 촉진되기 때문에 병이 호전되는 것이다.In the case of diabetes, the body warms up, and the burning of sugar in the blood becomes vigorous, so the content of sugar in the blood decreases, and the secretion of insulin is promoted by the regeneration of the pancreatic langelhans cells, thereby improving the disease.
수정은 크리스탈이라고도 불리워지며 무색 투명한 것은 안경 ㆍ조각 ㆍ인재(印材), 그 밖에 장식품으로 예전부터 사용되어 왔다. 현재도 아름다운 색조를 가지고 투명 또는 반투명한 것은 장식품으로 널리 사용되고 있다.Crystal is also called crystal, and colorless transparent has been used for a long time as glasses, sculptures, human resources, and other ornaments. Even today, beautiful tones and transparent or translucent are widely used as ornaments.
산화알미늄이라 불리는 알루니마는 화학식 Al2O3. 분자량은 101.96이다. 천연으로는 결정광물인 코런덤으로 산출되고, 또 순수한 코런덤이 착색된 루비와 사파이어도 있다. 여러 가지 형태를 가진 것이 알려져 있는데, 수산화알루미늄을 300℃ 이하로 가열하면 생기는α-산화알루미늄은 순수하고 가장 안정된 형태이다. 이밖에 알칼리를 약간 함유하는β-산화알루미늄수화물을 탈수하여 생기는 결정성이 나쁜 膨-산화알루미늄이 있으며, 또δ,ζ,η,θ,κ,x,ρ, 등도 알려져 있다.Alumina called aluminum oxide is represented by the chemical formula Al2O3. The molecular weight is 101.96. Naturally, there are ruby and sapphire, which are produced by corundum, a crystal mineral, and colored by pure corundum. It is known to have various forms. The α -aluminum oxide produced by heating aluminum hydroxide to 300 ° C. or lower is the purest and most stable form. In addition, there are some crystallized aluminum oxides having poor crystallinity resulting from the dehydration of β -aluminum oxide hydrate containing some alkali. Also known are δ , ζ , η , θ , κ , x , ρ , and the like.
α-산화알루미늄은 주로 알루미늄의 제조원료인데, 일반적으로 융해하여 석출시킨 결정은 굳기가 단단하고(모스굳기 9), 굴절률 1.76∼1.77이며, 인조보석 ·연마제(硏磨劑)로서도 사용된다. 결정이 발달하면 산이나 알칼리에 잘 녹지 않게 되므로, 소결하여 알루미나 자기(磁器)를 만든다. 膨-산화알루미늄 등 결정성이 나쁜 것은 탈수촉매로서의 작용이 강하여 촉매로 사용된다. 결정화하지 않은 산화알루미늄 또는 산화알루미늄수화물을 일반적으로 알루미나겔이라고 하는데 이것은 제산제 ·흡착제로 사용된다. α -aluminum oxide is mainly a raw material of aluminum. Generally, crystals melted and precipitated have a hard solidity (Moss solid 9), have refractive indices of 1.76 to 1.77, and are also used as artificial gemstones and abrasives. As crystals develop, they are less soluble in acids and alkalis, so they are sintered to form alumina porcelain. The poor crystallinity such as 膨 -aluminum oxide is used as a catalyst because of its strong function as a dehydration catalyst. Aluminum oxide or aluminum oxide hydrate that is not crystallized is generally called alumina gel, which is used as an antacid and adsorbent.
규석의 화학성분은 무수규산(無水硅酸) SiO2이다. 순도가 높고 흰색의 것을 백규석이라 하며, 페그마타이트,석영맥(石英脈),규암,처트(chert)에서 산출된다.규산분은 95~97% 이상이다. 특히 페그마타이트에 포함된 것은 장석과 함께 채굴되므로 장규석(長硅石)이라 한다. 백규석은 주로 유리,도자기,규소,페로실리콘의 원료이다.The chemical composition of silica is silicic anhydride SiO 2 . The white and high purity is called Paek Gyu Seok, and it is produced from pegmatite, quartz vein, quartzite and chert. Particularly contained in pegmatite is mined with feldspar, so it is called Jang Gyu-seok. Baek Gyu Seok is mainly a raw material of glass, ceramics, silicon and ferrosilicon.
연규석(軟硅石)은 석영질 암석이 풍화하여 토상(土狀)을 이룬 것으로 다소 점토가 섞여 있다. 내화(耐火) 모르타르나 시멘트의 혼합재로 사용되며 규산분이 90 % 정도이다. 노재(爐材) 규석은 처트의 일종으로, 철분을 함유하므로 적색을 띠는 각력(角礫)이 있으며 내화벽돌의 주원료이다. 내장석(內張石)은 규석의 작은 조각으로, 지름 5~15cm이며, 도자기 원료 분쇄용 볼밀(ball mill)의 내장용에 사용된다.Yeongyuseok (軟 硅石) is a clay that is weathered by quartz rock and is mixed with clay. It is used as a mixture of refractory mortar or cement and contains about 90% silicic acid. Furnace ash is a kind of chert. It contains iron, so it has red angular force and is the main raw material of refractory brick. Built-in stone (작은 張 石) is a small piece of silica, 5 to 15cm in diameter, is used for the interior of the ball mill for grinding ceramic material.
가성소다는 수산화나트륨이라고도 하며 부식성이 강하므로 가성(苛性)소다라하고, 화학식은 NaOH이다.Caustic soda is also called sodium hydroxide and is called caustic soda because it is highly corrosive, and the chemical formula is NaOH.
영국에서 무수탄산나트륨(소다회)과 수산화칼슘(소석회)을 반응시켜 처음으로 수산화나트륨을 공업 생산하는 데 성공한 것으로 알려져 있다. 처음에는 르블랑법으로 얻은 탄산나트륨을 원료로 썼기 때문에 질이 좋지 못하였으나, 그 후 암모니아-소다법이 완성되어 질이 좋은 수산화나트륨을 얻을 수 있게 되었다. 뒤이어 1900년경 염소(鹽素)를 부생(副生)하는 식염수(食鹽水)의 전기분해에 의한 방법이 완성되어, 염소의 수요 증가와 더불어 이 방법이 채택되면서부터(1968년쯤부터) 암모니아-소다법에 의한 생산은 중지되었다. 제품으로서 시판되고 있는 것에는 융해시킨 다음, 드럼통에 붓고 고체화시킨 것과 조각이나 막대 모양 또는 반구형(半球形)의 정제(錠劑)로 만든 것 등이 있다.It is known that the first industrial production of sodium hydroxide by reacting anhydrous sodium carbonate (soda ash) and calcium hydroxide (slaked lime) in the UK. At first, the sodium carbonate obtained by the LeBlanc method was used as a raw material, but the quality was not good. After that, the ammonia-soda method was completed to obtain good sodium hydroxide. Subsequently, by 1900, the method of electrolysis of brine byproducing chlorine was completed, and the ammonia-soda method was adopted (from around 1968) with the increase in demand for chlorine. Production by was stopped. Commercially available products include those which are melted, poured into a drum and solidified, and made into pieces, rods, or hemispherical tablets.
황산과 더불어 화학공업의 전분야에 걸쳐 널리 사용된다. 가장 큰 용도는 인조섬유공업 및 화학약품공업이지만, 그 밖에도 석유정제공업,펄프공업,방직공업,고무공업 등에 광범위하게 사용된다.In addition to sulfuric acid, it is widely used throughout the chemical industry. The biggest uses are artificial textiles and chemicals, but they are also widely used in petroleum, pulp, textile, and rubber industries.
금은 예부터 한방에서 금침을 만들어 악성종창을 치료하고, 가루약으로 혈액병,기관지천식 및 여러가지 질병치료에 이용되었다.Gold has been used to treat malignant swelling by making acupuncture in Korean traditional medicine, and to treat blood diseases, bronchial asthma and various diseases.
항생소약제가 나오기 전에는 금을 폐결핵 치료에도 사용하였으며, 금으로 만든 반지,목걸이,귀걸이등을 몸에 부착하고자 하는 것은 귀금속으로 가치보다 관절염치료에 좋은 영향을 주기 때문이다.Prior to antibiotic antibiotics, gold was used to treat pulmonary tuberculosis, and gold rings, necklaces, and earrings were attached to the body because they are precious metals and have a better effect on the treatment of arthritis.
은은 독과 반응하여 색깔이 변하고, 건강에 좋다고하여 예로부터 왕이나 상류계층이 많이 사용하였고, 고대 로마나 그리스에서는 은식기에 음식을 보관하면 신선하게 오랫동안 보관할 수 있는 것을 발견하였다.Silver reacts with poison and changes color and is good for health. It has been used by kings and upper classes for a long time. In ancient Rome and Greece, it was found that food can be kept fresh for a long time.
본초강목에서는 은을 몸에 지니면 오장이 편안하고, 심신이 안정되며, 사기를 내쫓고 몸을 가볍게 하여 명을 길게 한다고 나타나 있다.The herbaceous tree shows that if you have silver in your body, your five intestines are comfortable, your mind and body are stable, you can drive away the morale and lighten your body to lengthen your life.
본 발명은 이러한 특성을 지닌 맥반석과 그 혼합물을 보다 효과적으로 활용하는 다른 방법을 여러가지로 연구한 결과, 맥반석과 수정, 알루미나, 규석, 가성소다를 분말화하여 혼합하고, 이를 이용하여 요함부가 형성된 일정한 형태의 원적외선 반사체를 형성하고 요함부에 금과 은의 혼합물을 용융하여 충전시키므로서,According to the present invention, as a result of various studies on the effective use of the elvan and the mixture having such characteristics, the elvan and the crystals, alumina, silica and caustic soda are mixed and mixed to form a recessed portion using the same. By forming a far infrared reflector and melting and filling the recess with a mixture of gold and silver,
제조시 금과 은의 성분이 고열에 의해 산화되는 것을 방지함은 물론, 이를 매트리스나 베게, 방석등에 부착하여 사용할 수 있도록 하여 원적외선을 방사시키는 등의 신체에 이로운 작용에 의해 건강증진에 큰 효과가 있는 원적외선 방사용 조성물의 제조방법을 제공함에 본 발명의 목적이 있다.In addition to preventing the oxidation of gold and silver due to high heat during manufacture, it can be attached to mattresses, pillows, cushions, etc. to be used for beneficial effects on the body. It is an object of the present invention to provide a method for preparing a composition for far-infrared radiation.
도 1 은 본 발명의 맥반석을 주재로 혼합한 혼합물로 원적외선 반사체를 형성한 상태의 사시도.BRIEF DESCRIPTION OF THE DRAWINGS The perspective view of the state which formed the far infrared reflector by the mixture which mixed the elvan rock of this invention as a main body.
도 2 는 본 발명 원적외선 방사체의 요함부에 금과 은의 혼합물을 용융하여 충전시킨 상태를 도시한 사시도.2 is a perspective view showing a state in which the essential portion of the far-infrared radiator of the present invention is melted and filled with a mixture of gold and silver.
도 3 은 본 발명 원적외선 방사체의 단면도.3 is a cross-sectional view of the present invention far infrared emitter.
<도면의 주요 부분에 대한 부호의 설명><Explanation of symbols for the main parts of the drawings>
1 : 원적외선 방사체 2 : 요함부1: far infrared emitter 2: essential part
3 : 금은 혼합물3: gold and silver mixture
이하, 본 발명의 바람직한 실시예를 첨부된 도면을 참조하여 상세히 살펴본다.Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings.
도 1 은 본 발명의 맥반석을 주재로 혼합한 혼합물로 원적외선 반사체를 형성한 상태의 사시도이고, 도 2 는 본 발명 원적외선 방사체의 요함부에 금과 은의 혼합물을 용융하여 충전시킨 상태를 도시한 사시도, 도 3 은 본 발명 원적외선 방사체의 단면도이다.1 is a perspective view of a state in which a far infrared reflector is formed from a mixture of ganban stones of the present invention as a main component, and FIG. 2 is a perspective view showing a state in which a main portion of the far infrared radiator is melted and filled with a mixture of gold and silver; 3 is a cross-sectional view of the far-infrared radiator of the present invention.
본 발명 조성물은 맥반석분말 25중량%, 수정분말 10중량%, 알루미나 10중량%, 규석분말 10중량%, 가성소다 10중량%를 혼합하고, 이 혼합물의 0.1 ~ 0.3중량%에 해당하는 안료를 혼합하여 가열하여 용융한 후 일측면의 중앙에 요함부(2)가 형성된 원적외선 방사체(1)를 형성하고, 원적외선 방사체(1)의 중량대비 금분말 5중량%, 은분말 5중량%를 용융하여 전기한 요함부(2)에 충전시켜 응고시킨 것이다.The composition of the present invention is mixed with 25% by weight of elvan stone powder, 10% by weight of quartz powder, 10% by weight of alumina, 10% by weight of silica powder, 10% by weight of caustic soda, and 0.1 to 0.3% by weight of the pigment of the mixture is mixed. After heating and melting to form a far-infrared radiator 1 having the recessed part 2 in the center of one side, and melt 5% by weight of gold powder and 5% by weight of silver powder relative to the weight of the far infrared emitter 1 One recessed part 2 is filled and solidified.
이와 같은 조성물을 제조시에는 맥반석 25중량%, 수정 10중량%, 알루미나 10중량%, 규석 16중량%, 가성소다 10중량%를 분말화 하여 혼합하고, 이에 혼합물의 0.1 ~ 0.3 중량%에 해당하는 안료를 첨가하는 혼합공정과;In the preparation of such a composition, 25% by weight of ganbanite, 10% by weight of quartz, 10% by weight of alumina, 16% by weight of silica, 10% by weight of caustic soda powder, mixed, and corresponds to 0.1 to 0.3% by weight of the mixture A mixing step of adding a pigment;
혼합물을 1300 ~ 1400℃의 온도로 가열하여 용융시키는 용융공정과;A melting step of melting the mixture by heating to a temperature of 1300 to 1400 ° C .;
용융된 액체를 일정한 형상의 틀에 넣어 일측면에 요함부(2)가 형성된 원적외선 방사체(1)가 되도록 냉각시키는 경화공정과;A curing step of cooling the molten liquid into a far-infrared radiator 1 having recesses 2 formed on one side thereof in a mold having a predetermined shape;
경화된 조성물을 다시 500℃의 온도로 가열하여 강화시키는 재가열공정과;A reheating step of reinforcing and heating the cured composition to a temperature of 500 ° C .;
원적외선 방사체(1)의 중량대비 금 5중량%, 은 5중량%를 용용하여 요함부(2)에 충전시키고 냉각시키는 충전공정으로 이루어지는 것이다.5 wt% of gold and 5 wt% of silver to the weight of the far-infrared radiator 1 is melted to fill the recess 2 and to cool.
상기와 같은 본 발명의 제조방법에 의해 형성된 조성물을 매트리스나 방석, 베게등에 다수 부착하거나, 목걸이 등의 장신구로 제조하거나, 안테나 등에 설치하여 사용하게 되면, 조성물로 부터 발생하는 원적외선과 살균, 탈취작용에 의해 사용자의 건강증진은 물론, 위생에도 큰 기여를 할 수 있고 인체에 해로운 전자파를 차단할 수 있는 것이다.When the composition formed by the manufacturing method of the present invention as described above is attached to a large number of mattresses, cushions, pillows, etc., manufactured with ornaments such as necklaces, or installed on antennas, the far-infrared rays generated from the composition and sterilization and deodorization By the user's health as well as can make a significant contribution to hygiene and can block electromagnetic waves harmful to the human body.
본 발명은 맥반석과 그 혼합물을 보다 효과적으로 활용하는 다른 방법을 여러가지로 연구한 결과, 맥반석과 수정, 알루미나, 규석, 가성소다를 분말화하여 혼합하고, 이를 이용하여 요함부가 형성된 일정한 형태의 원적외선 반사체를 형성하고 요함부에 금과 은의 혼합물을 용융하여 충전시키므로서,According to the present invention, as a result of various studies on the use of elvan and its mixture more effectively, elvan and crystals, alumina, silica, caustic soda are powdered and mixed, and by using the same, a certain type of far-infrared reflector is formed. And melt and fill the essentials with a mixture of gold and silver,
제조시 금과 은의 성분이 고열에 의해 산화되는 것을 방지함은 물론, 이를 매트리스나 베게, 방석등에 부착하여 사용할 수 있도록 하여 원적외선을 방사시키는 등의 신체에 이로운 작용에 의해 건강증진에 큰 효과가 있는 것이다.In addition to preventing the oxidation of gold and silver due to high heat during manufacture, it can be attached to mattresses, pillows, cushions, etc. to be used for beneficial effects on the body. will be.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010052624A KR20030018500A (en) | 2001-08-29 | 2001-08-29 | Manufacturing method of composite radiating far-infrared ray |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010052624A KR20030018500A (en) | 2001-08-29 | 2001-08-29 | Manufacturing method of composite radiating far-infrared ray |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20030018500A true KR20030018500A (en) | 2003-03-06 |
Family
ID=27721475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020010052624A KR20030018500A (en) | 2001-08-29 | 2001-08-29 | Manufacturing method of composite radiating far-infrared ray |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20030018500A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100624193B1 (en) * | 2004-06-07 | 2006-09-19 | 한회임 | Chair for leisure |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR910016647A (en) * | 1990-03-16 | 1991-11-05 | 라창호 | Manufacturing method of heat resistant ceramic material emitting far infrared rays |
KR920009727A (en) * | 1990-11-01 | 1992-06-25 | 배영수 | Manufacturing method of medical far infrared radiation ceramic |
KR920019909A (en) * | 1991-04-01 | 1992-11-20 | 김용규 | Artificial charcoal with far-infrared radiation and its manufacturing method |
KR970059144A (en) * | 1996-01-19 | 1997-08-12 | 김효충 | Manufacturing method of far-infrared ray powder material |
KR980001935A (en) * | 1996-06-12 | 1998-03-30 | 김용미 | Multipurpose ore powder and manufacturing method |
KR200217158Y1 (en) * | 2000-05-08 | 2001-03-15 | 안정오 | Remote infrared radiator for mats |
KR20020073912A (en) * | 2001-03-16 | 2002-09-28 | 김용훈 | Far-infrared ray reflective and manu facturing method thereof |
KR101105962B1 (en) * | 2007-01-10 | 2012-01-18 | 콸콤 인코포레이티드 | Pilot structure with multiplexed unicast and sfn transmissions |
-
2001
- 2001-08-29 KR KR1020010052624A patent/KR20030018500A/en not_active Application Discontinuation
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR910016647A (en) * | 1990-03-16 | 1991-11-05 | 라창호 | Manufacturing method of heat resistant ceramic material emitting far infrared rays |
KR920009727A (en) * | 1990-11-01 | 1992-06-25 | 배영수 | Manufacturing method of medical far infrared radiation ceramic |
KR920019909A (en) * | 1991-04-01 | 1992-11-20 | 김용규 | Artificial charcoal with far-infrared radiation and its manufacturing method |
KR970059144A (en) * | 1996-01-19 | 1997-08-12 | 김효충 | Manufacturing method of far-infrared ray powder material |
KR980001935A (en) * | 1996-06-12 | 1998-03-30 | 김용미 | Multipurpose ore powder and manufacturing method |
KR200217158Y1 (en) * | 2000-05-08 | 2001-03-15 | 안정오 | Remote infrared radiator for mats |
KR20020073912A (en) * | 2001-03-16 | 2002-09-28 | 김용훈 | Far-infrared ray reflective and manu facturing method thereof |
KR101105962B1 (en) * | 2007-01-10 | 2012-01-18 | 콸콤 인코포레이티드 | Pilot structure with multiplexed unicast and sfn transmissions |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100624193B1 (en) * | 2004-06-07 | 2006-09-19 | 한회임 | Chair for leisure |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107032772A (en) | A kind of light-transmittance ceramics brick and preparation method thereof | |
KR100672980B1 (en) | A composition of Bioceramic emitting far infrarel rays and the manufacturing method thereof | |
KR101175999B1 (en) | Manufacturing process of a colour stone using basalt powder | |
KR20020073912A (en) | Far-infrared ray reflective and manu facturing method thereof | |
KR20030018500A (en) | Manufacturing method of composite radiating far-infrared ray | |
KR20020073913A (en) | Far-infrared ray reflective and manu facturing method thereof | |
CN106495479A (en) | A kind of bright red glaze and preparation method thereof | |
KR20060108856A (en) | The apparatus for food garbage | |
KR100335345B1 (en) | Composition for preparing porous alkalic ceramic ware and its products. | |
CN108821581A (en) | A kind of rough flambe and preparation method thereof for walking mud line with earthworm | |
KR101791776B1 (en) | Manufacturing method for heating apparatus | |
KR20100021018A (en) | Accessory and it's manufacturing method | |
KR100411492B1 (en) | A Method for Manufactuting Artificial Marble Using Slag | |
KR20030065917A (en) | Far-infrared ray reflective | |
KR970005871B1 (en) | Process for the preparation of artificial stone | |
El-Meliegy et al. | Machinable mica dental glass-ceramics | |
KR100313609B1 (en) | Method for manufacturing a artificial stone using a jade powder | |
SU925883A1 (en) | Method for producing ornamental and lining material | |
KR840001885B1 (en) | The process for preparing of glass tile | |
CN109320088A (en) | Compound opacifier and preparation method thereof and ceramic glaze and ceramics and application | |
JP3126558B2 (en) | Crystallized glass | |
KR20020073866A (en) | Far-infrared ray reflective and manu facturing method thereof | |
CN108264226A (en) | A kind of production method of unleaded cosmetics special-purpose bottle | |
US1724747A (en) | Process of preparing vitrified material | |
JPS6325258A (en) | Manufacture of low temperature burnt ceramic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |